Italia markets close in 23 minutes

ILMN Jun 2024 125.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,080,00 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente8,08
Aperto8,08
Denaro10,30
Lettera11,30
Prezzo d'esercizio125,00
Scadenza2024-06-21
Min-Max giorno8,08 - 8,08
Contratto - Min-MaxN/D
Volume2
Open Interest373
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera